To explore the prognostic relevance of tumor stage in CHEK1-mutated CRC, AI-HOPE-TP53 was queried to compare survival outcomes between patients with early-stage disease (Stage I–III) and those with advanced-stage disease (Stage IV). Here, CHEK1 is linked to neoplasm.